Company intelligence / Profile preview

Eckert & Ziegler

Berlin, Berlin, Germanyezag.com ↗

Ownership: Public · EUZ
Employees: ~1060
Development stage: Other

Overview

Eckert & Ziegler provides commercial-scale radioisotopes and devices for nuclear medicine and radiation therapy. The company also supports development of new radiopharmaceuticals through contract manufacturing and supply agreements. It has contributed to several preclinical/early clinical oncology programs in partnership with biotech companies such as Ariceum Therapeutics. Its own pipeline includes advanced preclinical-stage assets in oncology from past investments but primarily acts as a supplier/CDMO rather than a drug developer itself.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall molecule (as radiolabeled compounds)Device
Industry: Contract Manufacturing Organization

Partnerships

Ariceum Therapeutics – global supply agreement for radionuclide isotopes Ac225/Lu177 for next-generation radiotherapeutics development in precision oncology trials.NEMOD Immuntherapie AG – historical investment/collaboration in glycoprotein-based immunotherapies/radiolabeled antibodies/vaccines for oncology.Numerous pharmaceutical/biotech clients via CDMO/supply relationships.

Financials

Market cap: $150.5M
Total revenue: $3.7M
Enterprise value: $97.3M

Beyond the preview

Go deeper on Eckert & Ziegler.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eckert & Ziegler.

Explore the full profile